284 companies
Current coverage: European private startups and scale-ups.
Country
Ownership Status
Operational Status
Growth Stage
Financing Status
Regulatory Profile
Primary Industry
Secondary Industry
Regulatory Score
Clinical Evidence Score
Cobalt Score
Company Name
-
Aaron
General Information
Ownership Status
PrivateDescription
Aaron.ai is a Berlin-based digital health company providing an AI-powered virtual phone assistant for medical practices. It tackles high call volumes, staff overload and long wait times with a 24/7 conversational AI that categorizes appointment, prescription and sick note requests, summarizes patient details and flags emergencies. Operating in administrative automation and patient communication, it integrates with practice management systems, offers customizable greetings and after-hours modes, and delivers call summaries via a web app for clinicians and small-to-medium practices.Country
GermanyOperational Status
AcquiredPrimary Industry
Patient EngagementWebsite
aaron.aiLocation
BerlinGrowth Stage
Late StageSecondary Industry
TelehealthCompany Register #
HRB 167901 BYear Founded
2015Financing Status
–Company Value
$15–23mRegulatory Profile
Non-MD/IVD CompanySignals
Standard Membership Required
You must be a Standard member to access this content.
Already a member? Log in hereLast update:
2025-12-17T23:22:01.000Z -
Abscint
General Information
Ownership Status
PrivateDescription
Abscint is a molecular imaging company spun out of Vrije Universiteit Brussel that tackles invasive biopsy limitations by providing non-invasive, whole-body PET imaging using radiolabelled single-domain antibodies to visualize antigen expression. Its kit-form precursors enable on-site radiolabelling with short-lived PET radionuclides for same-day imaging within 60–90 minutes across all lesions. Operating in the digital health domain of diagnostic radiology and nuclear medicine, its tracers are designed for nuclear medicine departments, hospitals, imaging centers, clinicians and clinical trial sponsors.Country
BelgiumOperational Status
OperationalPrimary Industry
Molecular ImagingWebsite
abscint.comLocation
GanshorenGrowth Stage
SeedSecondary Industry
DiagnosticsCompany Register #
0749.828.410Year Founded
2020Financing Status
–Company Value
$13–20mRegulatory Profile
MD/IVD CompanySignals
Standard Membership Required
You must be a Standard member to access this content.
Already a member? Log in hereLast update:
2025-12-17T23:22:01.000Z -
Accexible
General Information
Ownership Status
PrivateDescription
Accexible is a digital health technology provider offering AI-powered speech analysis for early detection and monitoring of mental health conditions and cognitive disorders. It tackles challenges in timely identification and management of depression, mild cognitive impairment and dementia, where current methods may lack sensitivity or efficiency. The solution leverages AI models to analyze speech inputs via a live demo platform to detect disease indicators and enable monitoring. Operating in the AI diagnostics and monitoring domain, Accexible’s tools are intended for healthcare providers, Medicare Advantage plans and nurse care facilities.Country
SpainOperational Status
OperationalPrimary Industry
AI DiagnosticsWebsite
accexible.comLocation
BarcelonaGrowth Stage
Early GrowthSecondary Industry
Voice BiomarkersCompany Register #
B95886198Year Founded
2018Financing Status
–Company Value
$2MRegulatory Profile
MD/IVD CompanySignals
Standard Membership Required
You must be a Standard member to access this content.
Already a member? Log in hereLast update:
2025-12-17T23:22:01.000Z -
Acorai
General Information
Ownership Status
PrivateDescription
Acorai is a Swedish health tech startup founded in Helsingborg that develops non-invasive devices for heart failure management. It tackles limited access to intracardiac pressure monitoring in 60–64 million patients, which drives hospitalization and readmission rates. Its handheld Heart Monitor combines proprietary SAVE sensors—vibration, audio, electrical and external pressure—with AI and machine learning to estimate hemodynamic parameters, detect congestion up to 30 days before symptoms and guide therapy. Operating in cardiovascular remote monitoring and AI-driven diagnostics, it serves clinicians and hospitals.Country
SwedenOperational Status
OperationalPrimary Industry
Remote MonitoringWebsite
acorai.comLocation
HelsingborgGrowth Stage
Early GrowthSecondary Industry
CardiologyCompany Register #
428173900Year Founded
2019Financing Status
–Company Value
$31MRegulatory Profile
MD/IVD CompanySignals
Standard Membership Required
You must be a Standard member to access this content.
Already a member? Log in hereLast update:
2025-12-17T23:42:21.000Z -
Acurable
General Information
Ownership Status
PrivateDescription
Acurable is a venture-backed London MedTech company from Imperial College research, specializing in wearable devices for at-home monitoring. It addresses accurate, continuous monitoring of respiratory and cardiac biosignals in chronic conditions, overcoming clinic-based spot checks and complex wiring. Its AcuPebble devices use a patented acoustic sensor at the suprasternal notch to stream data to a mobile app and cloud, where proprietary algorithms extract biomarkers for automated reporting in a remote monitoring platform serving patients, clinicians, healthcare systems and researchers.Country
UKOperational Status
OperationalPrimary Industry
Remote MonitoringWebsite
acurable.comLocation
LondonGrowth Stage
Early GrowthSecondary Industry
WearablesCompany Register #
10310661Year Founded
2016Financing Status
–Company Value
$48–73MRegulatory Profile
MD/IVD CompanySignals
Standard Membership Required
You must be a Standard member to access this content.
Already a member? Log in hereLast update:
2025-12-17T23:42:21.000Z -
Ada Health
General Information
Ownership Status
PrivateDescription
Ada Health is a Berlin-based digital health company that uses AI to deliver personalized symptom assessment and care navigation. It addresses limited access to timely healthcare and system overload, especially in low- and middle-income countries. The AI-driven symptom checker app collects demographics, history and symptoms via a chatbot, matches them to over 3,600 conditions and 30,000 codes and provides real-time triage recommendations in health records. Operating in AI diagnostics and digital triage, it serves individuals, clinicians and healthcare organizations.Country
GermanyOperational Status
OperationalPrimary Industry
Clinical Decision SupportWebsite
ada.comLocation
BerlinGrowth Stage
Late GrowthSecondary Industry
Clinical Decision SupportCompany Register #
HRB 189710Year Founded
2011Financing Status
–Company Value
$120–180MRegulatory Profile
MD/IVD CompanySignals
Standard Membership Required
You must be a Standard member to access this content.
Already a member? Log in hereLast update:
2025-12-17T23:42:21.000Z